Join Our Penny Stock Newsletter

Innovus Pharmaceuticals, Inc. - INNV

RSI %R Tweets Wolf Odds
80 -37 158 74.525%

Industry: Drug Manufacturers - Major / Sector: Healthcare

INNV Chart

INNV Quote

Prev Close: 0.182
Open: 0.1820
Last Trade: 0.179
Change %: -1.650%
Change: -0.0030000
Volume: 1519106
Avg Vol: 960409
Relative Vol: 1.58
Day Range: 0.1751 -0.195
52-Week Range: 0.080 - 0.390
Market Cap: 12.41M
Float: 104.31M
Shares Outstanding: 151.3M
Insider Owned: 31.06%
Institution Owned: 0.00%
Beta: 4.93
PE Ratio: 0.00
EPS: -0.058

INNV Detailed Stats

RSI:79.98 %K:62.65 Wolf Odds: 74.525% Tweets Today:158 SMA14:0.1596
stochRSI:1.00 %D:71.74 Wolf Trend:0.33 Tweet Avg:119 Pivot Price:0.1830333
%R:-37.35 %B:0.89 Wolf 3-Day:0.41 Avg. Change 3-Day:+2.247% Resistance 1:0.1909667
MFI:65.37 Bandwidth:0.316422 Wolf 7-Day:0.41 Avg. Change 7-Day:+2.479% Resistance 2:0.2029333
WolfPeak:0.85 Vortex Indicator:0.38 Wolf 14-Day:0.41 Avg. Change 14-Day:+1.42% Support 1:0.1710667
ROC 7/14:20.9459/21.3559 Aroon Oscillator:92.8571 EOM:0.008584 Relative Vol:1.58 Support 2:0.1631333
RSI Alert:RSI Peak WolfPeak Alert:None Vortex Alert:None Aroon Alert:None EOM Alert:None

Featured News *


    INNV Description

    Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the commercialization, licensing, and development of non-prescription medicine and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph-compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream that enhances penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement of Arginine sexual and cognitive functions; and Androferti, a natural supplement to support overall male reproductive health and sperm quality. The company also offers Beyond Human testosterone booster, Ketones, krill oil, Omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; and UriVarx, a proprietary supplement for overactive bladder and urinary incontinence. The company?s pipeline products include FlutiCare, an over the counter drug for Rhinitis; Urocis for urinary tract infection; Xyralid, a lidocaine based cream for the relief of pain and symptoms caused by hemorrhoids; AllerVarx, a patented formulation produced in bilayer tablets; and AndroVit, a proprietary supplement to support overall prostate and male sexual health. The company markets and sells its products through commercial partners to primary care physicians, urologists, gynecologists, and therapists, as well as to other healthcare providers; and directly to consumers through online channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.

    INNV Comments

    Recent INNV Tweets

    Powered by Ekonomys ver. 9

    StockWolf is dedicated to Penny Stock quotes and data to provide information, news, and education on penny stocks to help in your due diligence.

    30min+ delay on data. All data is picked with automated algorithms and not vetted for accuracy. Please, read ALL information and disclaimers before using our service. StockWolf is not a licensed financial adviser, and not liable for your loses. Trade responsibly. This site is for education purposes only not a recommendation to buy/sell


    Stock Wolf Twitter

    Stock Wolf Facebook